PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 184 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $2,427,000 | +45.6% | 31,607 | -22.1% | 0.40% | +79.7% |
Q3 2015 | $1,667,000 | -19.8% | 40,563 | +38.0% | 0.22% | -21.8% |
Q2 2015 | $2,079,000 | -3.4% | 29,385 | +21.0% | 0.28% | +5.2% |
Q4 2014 | $2,153,000 | +46.3% | 24,280 | +51.5% | 0.27% | +22.7% |
Q2 2014 | $1,472,000 | – | 16,022 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |